Pain News and Research

Latest Pain News and Research

Research roundup: Confusing high priced for high quality care; Expanding digital records to all hospitals; Veterans and opiod use

An Experiment Shows That A Well-Designed Report On Costs And Quality Can Help Consumers Choose High-Value Health Care -- Researchers conducted an experiment with more than 1,400 people to see if the way information on quality and cost of care is displayed affects consumers' decision to choose a high value health care plan. The group was shown different presentations of the same information and was asked to pick their preferred plan.

10 Mar 2012

Concerns about aging in good health

Do men harbour concerns about aging in good health? Do they confide these concerns to their physicians? Are men's concerns the same as women's? The answers to these questions can be found in a large cross-sectional survey of 2325 Canadian men, aged 55 to 97 years old, led by Dr. Cara Tannenbaum, Geriatrician and the Michel Saucier Endowed Chair in Geriatric Pharmacology, Health and Aging at the Institut universitaire de gériatrie de Montréal (IUGM) which is affiliated with the Université de Montréal.

10 Mar 2012

Obesity, medical distrust contribute to high rates of prostate cancer in Louisiana

Factors such as increased risk for African-Americans, obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. Louisiana has the fourth highest prostate cancer death rate in the country and the sixth highest incidence rate, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.

9 Mar 2012

DC has highest prostate cancer incidence and death rate

Increased risk for African-Americans, medical distrust and negative attitudes toward testing contribute to high rates of prostate cancer in the District of Columbia. DC has the highest prostate cancer incidence rate and death rate in the country, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.

9 Mar 2012

State legislatures take on ultrasound mandate costs, employee health plans, Medicaid reform, malpractice

Democrats in the state Senate have sent Republican Gov. Bob McDonnell a list of conditions they want addressed before allowing a new state budget necessary to fund state services and operations to pass. … They want the state to pay for the ultrasound exams now mandated for women seeking abortions under a bill McDonnell signed Wednesday. ... And they want Medicaid eligibility restored for about 4,500 nursing home residents.

9 Mar 2012

Enrollment complete in Palatin's bremelanotide Phase 2B trial for FSD

Palatin Technologies, Inc. today announced it has completed enrollment in its Phase 2B clinical trial evaluating the efficacy and safety of bremelanotide for treatment of female sexual dysfunction.

9 Mar 2012

Unigene fourth quarter net income increases to $4.4 million

Unigene Laboratories, Inc., today announced financial results for the fourth quarter and full-year ended December 31, 2011.

9 Mar 2012

FDA approves Teva's ProAir HFA with dose counter for asthma, COPD and EIB

Teva Respiratory announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir HFA with a dose counter for use in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.

8 Mar 2012

Get ready for Be Medicinewise Week 2012

Building on the success of last year’s inaugural event, the week will urge all Australians to stop, think and learn more about the medicines they are using and encourage them to seek information to make better decisions about their health.

8 Mar 2012

Dr. Falk Pharma, Lipid Therapeutics enter license agreement for LT-02 to treat UC

Dr. Falk Pharma GmbH and Lipid Therapeutics, a biotechnology company focused on novel treatments for inflammatory bowel disease, today announced that they have entered into a licensing agreement for the European rights to Lipid Therapeutics' lead product, LT-02, for ulcerative colitis.

8 Mar 2012

Australian TGA approves Bayer's EYLEA for treatment of wet AMD

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has received approval from the Australian Therapeutic Goods Administration (TGA) for EYLEA (aflibercept) Injection for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD) at a recommended dose of 2 milligrams (mg) via intravitreal injection per month for three consecutive months, followed by 2 milligrams via intravitreal injection every two months.

8 Mar 2012

Women with breast pain do not gain benefit from imaging

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have found that women with breast pain who receive imaging (mammograms, MRIs or ultrasounds) as part of breast pain evaluation, undergo follow-up diagnostic testing, but do not gain benefit from these additional studies.

8 Mar 2012

Zalicus fourth quarter revenue decreases to $8.2 million

Zalicus Inc. today reported financial results for the fourth quarter and year ended December 31, 2011.

8 Mar 2012

BioLineRx receives European patent for BL-1020 to treat schizophrenia

BioLineRx, a biopharmaceutical development company, announced today that a European patent has been granted claiming BL-1020's composition and its use for the treatment of schizophrenia.

8 Mar 2012

Transcranial direct current stimulation safe and effective treatment for depression

Stimulating the brain with a weak electrical current is a safe and effective treatment for depression and could have other surprise benefits for the body and mind, a major Australian study of transcranial Direct Current Stimulation (tDCS) has found.

7 Mar 2012

FDA approves Covidien's EverFlex Self-Expanding Peripheral Stent System

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has approved the EverFlex Self-Expanding Peripheral Stent System for use in the superficial femoral artery (SFA) and/or the proximal popliteal artery.

7 Mar 2012

New clinical trial: Pycnogenol improves signs and symptoms of menopause

Half the population experiences menopause, and for those women, it is a condition they will experience for approximately one third of their lifetime. Alternative or natural remedies are an easy, effective way to improve signs and symptoms linked to the menopausal transition, without side effects.

7 Mar 2012

A novel approach to treating rheumatoid arthritis

Rheumatoid arthritis is a crippling disease and is caused when the body's own immune system attacks the joints and leads to chronic pain and inflammation. A team from Newcastle University funded by Arthritis Research UK have discovered an approach which could effectively prevents white blood cells from reaching the joints and causing more damage.

7 Mar 2012

Veterans prescribed more opioid pain killers: Study

According to a new government study Morphine and similar powerful painkillers are sometimes prescribed to recent war veterans suffering from post-traumatic stress along with physical pain. The study suggests that these vets are at high risk for drug and alcohol abuse, but they're two times more likely to get prescriptions for addictive painkillers than vets with only physical pain.

7 Mar 2012

Yoga may be effective in treating patients with stress-related psychological and medical conditions

An article by researchers from Boston University School of Medicine (BUSM), New York Medical College (NYMC), and the Columbia College of Physicians and Surgeons (CCPS) reviews evidence that yoga may be effective in treating patients with stress-related psychological and medical conditions such as depression, anxiety, high blood pressure and cardiac disease.

7 Mar 2012